Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting
Codexis, Inc. (CDXS)
Last codexis, inc. earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.codexis.com/investors
Company Research
Source: GlobeNewswire
REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will participate in a presentation and panel discussion at the upcoming RNA Leaders annual meeting, being held September 4-5, 2024, in San Diego, CA. The Company’s presentations will focus on the use of enzymes to drive the scalable and cost-effective manufacture of short inhibitory ribonucleic acid (siRNA) duplexes. During a keynote panel presentation, Stefan Lutz, PhD, Codexis Senior Vice President of Research, in addition to other RNA industry leaders, will discuss how the biopharmaceutical industry is developing new solutions to advance RNA manufacturing, address production capacities and establish new approaches to streamline clinical trials and standardize protocols. The Company’s second presentation will focus on ligation, which enables the joining of siRNA fragments to generate full-length siRNA duplexes. This approach redu
Show less
Read more
Impact Snapshot
Event Time:
CDXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDXS alerts
High impacting Codexis, Inc. news events
Weekly update
A roundup of the hottest topics
CDXS
News
- Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.MarketBeat
- Pleasing Signs As A Number Of Insiders Buy Codexis Stock [Yahoo! Finance]Yahoo! Finance
- Codexis Announces New Employment Inducement GrantsGlobeNewswire
- Codexis to Participate in Upcoming Healthcare ConferencesGlobeNewswire
- Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.MarketBeat
CDXS
Earnings
- 8/8/24 - Miss
CDXS
Sec Filings
- 9/26/24 - Form 4
- 9/26/24 - Form SC
- 9/23/24 - Form 4
- CDXS's page on the SEC website